Jonas Schoendube
Director/Board Member at Cytena Bioprocess Solutions
Network origin in Jonas Schoendube first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
cytena GmbH
 cytena GmbH BiotechnologyHealth Technology cytena GmbH develops a device for separating of single cells. It has developed a device called cy-Clone to separate single cells and these single cells are required for the development of state-of-the-art drugs, so-called biologicals as well as for the genetic analysis of single cells for cancer and stem cell research, the cy-Clone is supported by an automated imaging process to encapsulate cells in droplets, which are delivered to any type of substrate. The company was founded by Peter Koltay, Benjamin Steimle, Jonas Schoendube and Andre Gross in August 2014 and is headquartered in Freiburg, Germany.
3
| Subsidiary | Biotechnology | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jonas Schoendube via their personal network
| Company | Sector | Related people | Main position |
|---|
Statistics
International
Sectoral
Operational
| Founder | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Director of Finance/CFO | 1 |
| Public Communications Contact | 1 |
Most connected contacts
| Insiders | |
|---|---|
| Andre Gross | 1 |
| Peter Koltay | 1 |
| Benjamin Steimle | 1 |
- Stock Market
- Insiders
- Jonas Schoendube
- Company connections
